{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:35:54Z","timestamp":1789054554819,"version":"build-2803163510"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"18","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1 R01 CA 216991"],"award-info":[{"award-number":["1 R01 CA 216991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1 R01 CA 160335"],"award-info":[{"award-number":["1 R01 CA 160335"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic metastasis is the major cause of death from melanoma, the most lethal form of skin cancer. Although most patients with melanoma exhibit a substantial gap between onset of primary and metastatic tumors, signaling mechanisms implicated in the period of metastatic latency remain unclear. We hypothesized that melanoma circulating tumor cells (CTC) home to and reside in the bone marrow during the asymptomatic phase of disease progression. Using a strategy to deplete normal cell lineages (Lin\u2212), we isolated CTC-enriched cell populations from the blood of patients with metastatic melanoma, verified by the presence of putative CTCs characterized by melanoma-specific biomarkers and upregulated gene transcripts involved in cell survival and prodevelopment functions. Implantation of Lin\u2212 population in NSG mice (CTC-derived xenografts, i.e., CDX), and subsequent transcriptomic analysis of ex vivo bone marrow\u2013resident tumor cells (BMRTC) versus CTC identified protein ubiquitination as a significant regulatory pathway of BMRTC signaling. Selective inhibition of USP7, a key deubiquinating enzyme, arrested BMRTCs in bone marrow locales and decreased systemic micrometastasis. This study provides first-time evidence that the asymptomatic progression of metastatic melanoma can be recapitulated in vivo using patient-isolated CTCs. Furthermore, these results suggest that USP7 inhibitors warrant further investigation as a strategy to prevent progression to overt clinical metastasis.<\/jats:p>\n                  <jats:p>Significance: These findings provide insights into mechanism of melanoma recurrence and propose a novel approach to inhibit systematic metastatic disease by targeting bone marrow-resident tumor cells through pharmacological inhibition of USP7.<\/jats:p>\n                  <jats:p>Graphical Abstract:\u2008http:\/\/cancerres.aacrjournals.org\/content\/canres\/78\/18\/5349\/F1.large.jpg. Cancer Res; 78(18); 5349\u201362. \u00a92018 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-18-0644","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T10:28:36Z","timestamp":1531996116000},"page":"5349-5362","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow\u2013Resident Melanoma CTCs"],"prefix":"10.1158","volume":"78","author":[{"given":"Monika","family":"Vishnoi","sequence":"first","affiliation":[{"name":"1Biomarker Research Program Center, Houston Methodist Research Institute, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-9811","authenticated-orcid":false,"given":"Debasish","family":"Boral","sequence":"additional","affiliation":[{"name":"1Biomarker Research Program Center, Houston Methodist Research Institute, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Liu","sequence":"additional","affiliation":[{"name":"1Biomarker Research Program Center, Houston Methodist Research Institute, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Sprouse","sequence":"additional","affiliation":[{"name":"1Biomarker Research Program Center, Houston Methodist Research Institute, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yin","sequence":"additional","affiliation":[{"name":"1Biomarker Research Program Center, Houston Methodist Research Institute, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debalina","family":"Goswami-Sewell","sequence":"additional","affiliation":[{"name":"1Biomarker Research Program Center, Houston Methodist Research Institute, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Tetzlaff","sequence":"additional","affiliation":[{"name":"2Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0977-0912","authenticated-orcid":false,"given":"Michael A.","family":"Davies","sequence":"additional","affiliation":[{"name":"2Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-7765","authenticated-orcid":false,"given":"Isabella C. Glitza","family":"Oliva","sequence":"additional","affiliation":[{"name":"2Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Marchetti","sequence":"additional","affiliation":[{"name":"1Biomarker Research Program Center, Houston Methodist Research Institute, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"2022061706033186100_bib1","volume-title":"SEER cancer statistics review, 1975-2014","author":"Howlader"},{"key":"2022061706033186100_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2022061706033186100_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/CGM.S31244","article-title":"Cancer metastases: early dissemination and late recurrences","volume":"8","author":"Friberg","year":"2015","journal-title":"Cancer Growth Metastasis"},{"key":"2022061706033186100_bib4","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI42002","article-title":"Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma","volume":"120","author":"Eyles","year":"2010","journal-title":"J Clin Invest"},{"key":"2022061706033186100_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41467-017-02674-y","article-title":"Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma","volume":"9","author":"Werner-Klein","year":"2018","journal-title":"Nat Commun"},{"key":"2022061706033186100_bib6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1172\/JCI43424","article-title":"Early tumor dissemination, but late metastasis: insights into tumor dormancy","volume":"120","author":"Rocken","year":"2010","journal-title":"J Clin Invest"},{"key":"2022061706033186100_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamasurg.2013.1345","article-title":"Early diagnosis of metastatic disease in melanoma: does it make a difference?: Comment on \"Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result\"","volume":"148","author":"Wong","year":"2013","journal-title":"JAMA Surg"},{"key":"2022061706033186100_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamasurg.2013.1335","article-title":"Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result","volume":"148","author":"Jones","year":"2013","journal-title":"JAMA Surg"},{"key":"2022061706033186100_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature22977","article-title":"Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine","volume":"546","author":"Olmeda","year":"2017","journal-title":"Nature"},{"key":"2022061706033186100_bib10","article-title":"Research on melanoma\u2014a glimpse into current directions and future trends","volume-title":"Current insight into the metastatic process and melanoma cell dissemination","author":"Bourgault-Villada","year":"2011"},{"key":"2022061706033186100_bib11","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1136\/bcr.07.2009.2073","article-title":"Giant cutaneous melanomas: evidence for primary tumour induced dormancy in metastatic sites?","volume":"2009","author":"Tseng","year":"2009","journal-title":"BMJ Case Rep"},{"key":"2022061706033186100_bib12","first-page":"237","article-title":"Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas","volume":"14","author":"Ghossein","year":"2000","journal-title":"In Vivo"},{"key":"2022061706033186100_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/1471-2407-14-423","article-title":"Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma","volume":"14","author":"Klinac","year":"2014","journal-title":"BMC Cancer"},{"key":"2022061706033186100_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41467-017-00196-1","article-title":"Molecular characterization of breast cancer CTCs associated with brain metastasis","volume":"8","author":"Boral","year":"2017","journal-title":"Nat Commun"},{"key":"2022061706033186100_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bjc.6603594","article-title":"Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice","volume":"96","author":"Thies","year":"2007","journal-title":"Br J Cancer"},{"key":"2022061706033186100_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/CMR.0000000000000025","article-title":"Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma","volume":"24","author":"Khoja","year":"2014","journal-title":"Melanoma Res"},{"key":"2022061706033186100_bib17","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/jid.2015.127","article-title":"Circulating melanoma cell subpopulations: their heterogeneity and differential responses to treatment","volume":"135","author":"Gray","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2022061706033186100_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.celrep.2014.03.039","article-title":"Isolation and molecular characterization of circulating melanoma cells","volume":"7","author":"Luo","year":"2014","journal-title":"Cell Rep"},{"key":"2022061706033186100_bib19","first-page":"1102","article-title":"Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients","author":"Kiyohara","year":"2014","journal-title":"Methods Mol Biol"},{"key":"2022061706033186100_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"22","author":"Chauhan","year":"2012","journal-title":"Cancer Cell"},{"key":"2022061706033186100_bib21","doi-asserted-by":"crossref","first-page":"17533","DOI":"10.1038\/srep17533","article-title":"The isolation and characterization of CTC subsets related to breast cancer dormancy","volume":"5","author":"Vishnoi","year":"2015","journal-title":"Sci Rep"},{"key":"2022061706033186100_bib22","first-page":"e","article-title":"Quantifying chromogen intensity in immunohistochemistry via reciprocal intensity","volume":"2","author":"Nguyen","year":"2013","journal-title":"Cancer InCytes"},{"key":"2022061706033186100_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-1875-1_3","article-title":"PCR based determination of mitochondrial DNA copy number in multiple species","volume":"1241","author":"Rooney","year":"2015","journal-title":"Methods Mol Biol"},{"key":"2022061706033186100_bib24","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/1078-0432.CCR-10-3234","article-title":"Reporting the capture efficiency of a filter-based microdevice: a CTC is not a CTC unless it is CD45 negative\u2013letter","volume":"17","author":"Attard","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2022061706033186100_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/cancers6010323","article-title":"Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method","volume":"6","author":"Mazzini","year":"2014","journal-title":"Cancers"},{"key":"2022061706033186100_bib26","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.30202","article-title":"Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma","volume":"139","author":"Ortega-Martinez","year":"2016","journal-title":"Int J Cancer"},{"key":"2022061706033186100_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.neo.2016.06.007","article-title":"Impaired lymphocytes development and xenotransplantation of gastrointestinal tumor cells in prkdc-null SCID zebrafish model","volume":"18","author":"Jung","year":"2016","journal-title":"Neoplasia"},{"key":"2022061706033186100_bib28","doi-asserted-by":"crossref","first-page":"35508","DOI":"10.18632\/oncotarget.16348","article-title":"Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated\/deleted clones","volume":"8","author":"Carra","year":"2017","journal-title":"Oncotarget"},{"key":"2022061706033186100_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573406413666171020115539","article-title":"USP7: Target validation and drug discovery for cancer therapy","volume":"14","author":"Zhou","year":"2018","journal-title":"Med Chem"},{"key":"2022061706033186100_bib30","doi-asserted-by":"crossref","first-page":"e1780v1","DOI":"10.7717\/peerj-cs.67","article-title":"OncoLnc: linking TCGA survival data to mRNAs, miRNAs, lncRNAs","volume":"2","author":"Anaya","year":"2016","journal-title":"PeerJ Computer Sci"},{"key":"2022061706033186100_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1673-8527(08)60099-5","article-title":"Number matters: control of mammalian mitochondrial DNA copy number","volume":"36","author":"Clay Montier","year":"2009","journal-title":"J Genet Genomics"},{"key":"2022061706033186100_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/19336918.2014.972781","article-title":"Tenascin-C signaling in melanoma","volume":"9","author":"Shao","year":"2015","journal-title":"Cell Adh Migr"},{"key":"2022061706033186100_bib33","doi-asserted-by":"crossref","first-page":"14311","DOI":"10.1007\/s13277-016-5298-1","article-title":"FBXO25 promotes cell proliferation, invasion, and migration of NSCLC","volume":"37","author":"Jiang","year":"2016","journal-title":"Tumour Biol"},{"key":"2022061706033186100_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10585-011-9390-z","article-title":"RGS22, a novel cancer\/testis antigen, inhibits epithelial cell invasion and metastasis","volume":"28","author":"Hu","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"2022061706033186100_bib35","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1158\/0008-5472.CAN-16-2065","article-title":"Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma","volume":"77","author":"Marchan","year":"2017","journal-title":"Cancer Res"},{"key":"2022061706033186100_bib36","doi-asserted-by":"crossref","first-page":"e73473","DOI":"10.1371\/journal.pone.0073473","article-title":"New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion","volume":"8","author":"Margue","year":"2013","journal-title":"PLoS One"},{"key":"2022061706033186100_bib37","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1158\/0008-5472.CAN-11-1194","article-title":"TGF-beta\/SMAD\/GLI2 signaling axis in cancer progression and metastasis","volume":"71","author":"Javelaud","year":"2011","journal-title":"Cancer Res"},{"key":"2022061706033186100_bib38","doi-asserted-by":"crossref","first-page":"R459","DOI":"10.1016\/j.cub.2013.04.032","article-title":"Cell biology: DUBing CP110 controls centrosome numbers","volume":"23","author":"Barenz","year":"2013","journal-title":"Curr Biol"},{"key":"2022061706033186100_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10689-015-9826-8","article-title":"POLE mutations in families predisposed to cutaneous melanoma","volume":"14","author":"Aoude","year":"2015","journal-title":"Fam Cancer"},{"key":"2022061706033186100_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"key":"2022061706033186100_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1479-5876-9-70","article-title":"Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients","volume":"9","author":"Liu","year":"2011","journal-title":"J Transl Med"},{"key":"2022061706033186100_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2184.1992.tb01435.x","article-title":"Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells","volume":"25","author":"Bruno","year":"1992","journal-title":"Cell Prolif"},{"key":"2022061706033186100_bib43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.chembiol.2012.02.007","article-title":"Discovery of specific inhibitors of human USP7\/HAUSP deubiquitinating enzyme","volume":"19","author":"Reverdy","year":"2012","journal-title":"Chem Biol"},{"key":"2022061706033186100_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/MCB.00639-13","article-title":"A role for USP7 in DNA replication","volume":"34","author":"Jagannathan","year":"2014","journal-title":"Mol Cell Biol"},{"key":"2022061706033186100_bib45","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1158\/1078-0432.CCR-14-1027","article-title":"Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB\/C melanoma patients with BRAFV600 mutations","volume":"20","author":"Bucheit","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2022061706033186100_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13287-017-0637-8","article-title":"Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells","volume":"8","author":"Tang","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"2022061706033186100_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ccr.2013.09.007","article-title":"Origins of metastatic traits","volume":"24","author":"Vanharanta","year":"2013","journal-title":"Cancer Cell"},{"key":"2022061706033186100_bib48","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3892\/or.2015.4209","article-title":"RGS22 inhibits pancreatic adenocarcinoma cell migration through the G12\/13 alpha subunit\/F-actin pathway","volume":"34","author":"Hu","year":"2015","journal-title":"Oncol Rep"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/78\/18\/5349\/2771381\/5349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/78\/18\/5349\/2771381\/5349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:01:13Z","timestamp":1655470873000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/78\/18\/5349\/631762\/Targeting-USP7-Identifies-a-Metastasis-Competent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":48,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2018,9,14]]},"published-print":{"date-parts":[[2018,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-18-0644","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22420583.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420586","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420583","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22420586.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6510692.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6510692","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]}}}